Skip to main content
. 2021 Apr 27;12:666137. doi: 10.3389/fimmu.2021.666137

Figure 10.

Figure 10

The combination of the IRS signature and clinicopathological features improves survival prediction. (A) A nomogram was constructed to predict 3- and 5-year OS in individual breast cancer patients. (B, C) Calibration analysis indicated a high accuracy of 3- and 5-year survival prediction. (D) tROC analysis demonstrated that the nomogram was the most stable and powerful predictor for OS among all the clinical variables.